

#407 DIGEST: Bempedoic acid and cardiac risk, Alpha-Gal Syndrome, Orforglipron, Zuranolone, DOACs for VTE of Malignancy, mAbs for Dementia, New Med for Smoking Cessation, Kiwis and Constipation
Sep 11, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11
Introduction
00:00 • 2min
The Clear Outcomes Trial of Benpedoic Acid
01:49 • 6min
Risk of Gout and Elevated LFTs in Bempedoic Acid Trial
07:34 • 3min
Statin Tolerance and the Potential of Bempedoic Acid
10:16 • 8min
Comparing DOACs and low molecular weight heparin for treating VTE in cancer patients
18:02 • 5min
Comparing DOACs and Low Molecular Weight Heparin for VTE in Cancer Patients
22:45 • 4min
Dosing of Injectable Anticoagulants and Challenges with Weight-based Dosing
26:29 • 4min
A New Medication for Smoking Cessation
30:42 • 14min
Study on Kiwi Consumption for Constipation and Pathway Sponsor Ad
44:48 • 3min
Trial on Non-Peptide GLP-1 Receptor Agonist for Weight Loss
48:17 • 15min
Management of Patients in Addiction Medicine and Mental Health Issues
01:02:58 • 4min